$5.34
-0.40 (-6.97%)
Open$5.70
Previous Close$5.74
Day High$5.71
Day Low$5.34
52W High$13.64
52W Low$10.02
Volume—
Avg Volume67.0K
Market Cap35.98M
P/E Ratio16.10
EPS$0.80
SectorBiotechnology
Analyst Ratings
Buy
11 analysts
Price Target
+226.6% upside
Current
$5.34
$5.34
Target
$17.44
$17.44
$9.95
$17.44 avg
$18.08
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 21.13M | 21.81M | 22.76M |
| Net Income | -3,613,419 | -4,862,244 | -3,816,324 |
| Profit Margin | -17.1% | -22.3% | -16.8% |
| EBITDA | -5,916,348 | -5,182,437 | -6,404,056 |
| Free Cash Flow | -5,168,786 | -3,508,220 | -3,760,769 |
| Rev Growth | -1.2% | +1.1% | +19.2% |
| Debt/Equity | 0.72 | 0.63 | 0.61 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |